Top Markets
#1 GEKKO GEKKO +52.86%
#2 ADO Protocol ADO Protocol +38.61%
#3 Pons Pons +38.26%
#4 Prom Prom +32.61%
#5 Helium Helium +29.77%
#6 CZ'S Dog CZ'S Dog +21.03%
#7 龙虾 (Lobster) 龙虾 (Lobster) +19.96%
#8 TENDIES TENDIES +19.66%
#9 Main Street Yield Main Street Yield +17.48%
#10 OpenGradient OpenGradient +17.07%
Coin of the day
GEKKO GEKKO
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Nichi-Iko Pharmaceutical Co., Ltd. Nichi-Iko Pharmaceutical Co., Ltd.

Nichi-Iko Pharmaceutical Co., Ltd.

4541
Classifica tra le azioni #8954
Nichi-Iko Pharmaceutical Co., Ltd. actively manufactures, distributes, imports,... Nichi-Iko Pharmaceutical Co., Ltd. actively manufactures, distributes, imports, and sells a wide variety of pharmaceutical products. Operating through its Sagent Group and Nichi-Iko Group segments, the company primarily focuses on the development and production of generic drugs. Its extensive product line encompasses antidiabetic, antacid, and antireflux agents, as well as beta-blockers, hypnotics, sedatives, angiotensin II antagonists (including combinations with diuretics), dyslipidemic agents, and calcium antagonists. These offerings target conditions affecting the circulatory, digestive, respiratory, central, and peripheral nervous systems, among others. Beyond pharmaceuticals, the company is also involved in packaging design and exports its products internationally. Established in 1947 as Nihon Iyakuhin Kogyo Co., Ltd., the firm officially became Nichi-Iko Pharmaceutical Co., Ltd. in 2005 and is headquartered in Toyama, Japan.
Prezzo delle azioni
$0.22167204
Ultima sincronizzazione: 2024-08-21
Capitalizzazione di mercato
$1.13B
Variazione (1 giorno)
1.08%
Variazione (1 anno)
0.00%
Paese
JP
Scambia Nichi-Iko Pharmaceutical Co., Ltd. (4541)

Categoria

Healthcare
Ricavi di Nichi-Iko Pharmaceutical Co., Ltd. (4541)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Nichi-Iko Pharmaceutical Co., Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Nichi-Iko Pharmaceutical Co., Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN